Status:
COMPLETED
Biomarkers in Tumor Tissue Samples From Younger Patients With Rhabdomyosarcoma
Lead Sponsor:
Children's Oncology Group
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Alveolar Childhood Rhabdomyosarcoma
Childhood Rhabdomyosarcoma
Eligibility:
All Genders
Brief Summary
This research trial studies biomarkers in tumor tissue samples from younger patients with rhabdomyosarcoma. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctor...
Detailed Description
PRIMARY OBJECTIVES: I. To demonstrate CRKL expression at the protein level in rhabdomyosarcoma tumors by tissue microarray (TMA). OUTLINE: Archived tumor tissue samples are analyzed for CRKL expres...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Alveolar rhabdomyosarcoma and embryonal rhabdomyosarcoma specimens from the Children Oncology Group (COG) tumor microarrays (TMAs)
Exclusion
Key Trial Info
Start Date :
December 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2016
Estimated Enrollment :
77 Patients enrolled
Trial Details
Trial ID
NCT01496573
Start Date
December 1 2011
End Date
May 1 2016
Last Update
May 19 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Oncology Group
Monrovia, California, United States, 91006-3776